Studies showed that β-ionone inhibits the proliferation [50,56,66,67] and induced invasiveness [65,66,70] of prostate cancer cells via activation of OR51E2, whereas β-ionone mediated-activation of OR51E2 inhibited proliferation and migration of melanocytes and induced melanogenesis [49,68]. The gene discussed is OR51E2; the disease is prostate carcinoma.